Lv5
1010 积分 2024-06-12 加入
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
24天前
已完结
Liquid biopsy and minimal residual disease — latest advances and implications for cure
26天前
已完结
PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
1个月前
已完结
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
1个月前
已完结
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
1个月前
已完结
Mutational landscape and significance across 12 major cancer types
1个月前
已完结
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
1个月前
已完结
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
1个月前
已完结
Abstract PS5-12: Preliminary correlative analysis of clinical outcomes with PIK3CA mutation (mut) status from a phase I/Ib study of GDC-0077 in patients (pts) with hormone receptor-positive/HER2-negative metastatic breast cancer (HR+/HER2- mBC)
1个月前
已关闭
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
1个月前
已完结
皖公网安备34019202002308
